|
0
|
|
Small-molecule RAS/RAF inhibitors target RAS-driven cancers via allosteric RAF disruption.
(nature.com)
|
Yoshikawa Y
…
Shima F
Nature Communications
2026-08-27
|
#cancer
#inhibitor
#signaling
#amr
|
|
0
|
|
Systematic analysis of network-driven adaptive resistance to CDK4/6 and oestrogen receptor inhibition using meta-dynamic network modelling.
(elifesciences.org)
|
Hart A
…
Nguyen LK
eLife
2026-08-27
|
#amr
#cancer
#signaling
#systems biology
#modeling
|
|
0
|
|
nf-core/pacsomatic: a scalable somatic analytic pipeline using PacBio HiFi data.
(academic.oup.com)
|
Zhang W
…
Chang TC
Bioinformatics
2026-08-27
|
#cancer
#sequencing
#methylation
#variants
#pipeline
|
|
0
|
|
Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity.
(linkinghub.elsevier.com)
|
Fabre T
…
Gieseck RL 3rd
Cell Reports
2026-08-27
|
#cancer
#immunotherapy
#cytokine
#immunity
#checkpoint-inhibitors
|
|
0
|
|
Pervasive tissue specificity of driver genes revealed by mutational analysis of 265 cancer types.
(linkinghub.elsevier.com)
|
Chen J
…
Haigis KM
iScience
2026-08-27
|
#cancer
#mutation
#oncogenesis
#genomics
|